Our study analyzes the pathway leading to the ameliorated phenotype of BACHD-SD mice and underscores the critical importance of future studies that identify enzymes responsible for regulating HTT phosphorylation and their potential as therapeutic HD targets. This evidence concerns the gene HTT and Huntington disease.